T1	intervention 8 57	granulocyte colony-stimulating factor prophylaxis
T2	condition 172 191	febrile neutropenia
T3	eligibility 656 783	patients with breast cancer who were considered fit enough to receive 3-weekly polychemotherapy, but also had > 20% risk for FN
T4	control 970 982	standard arm
T5	total-participants 1146 1149	167
T6	control-participants 1247 1249	84
T8	outcome 1349 1362	episode of FN
T9	intervention-participants 1380 1382	83
T10	outcome 1469 1479	FN episode
T7	cv-bin-abs 1322 1327	eight
T12	cv-bin-percent 1329 1332	10%
T13	iv-bin-abs 1453 1455	30
T14	iv-bin-percent 1457 1460	36%
